Home Search

direct oral anticoagulants - search results

If you're not happy with the results, please do another search

Latest News

Alternative timing method for direct oral anticoagulants following ischaemic stroke with atrial fibrillation deemed feasible

Sarah Croft- 16th February 2022

Latest News

Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation

Jocelyn Hudson- 23rd May 2019

Latest News

Apixaban associated with lower risk of gastrointestinal bleeding in AF patients compared to other oral anticoagulants

willdate- 1st November 2022

Latest News

Anticoagulants fail to improve survival from COVID-19, Swedish study finds

willdate- 2nd December 2020

Latest News

ACC publishes pathway on the management of bleeding in patients on oral anticoagulants

willdate- 15th July 2020

Features

Risk of dementia higher without oral anticoagulants for AF

zohman- 15th December 2017

Latest News

AF patients with intermediate-to-high-risk of stroke often prescribed aspirin instead of anticoagulants

BIBA Publishing- 21st June 2016

Latest News

Verseon presents data on new class of anticoagulants at the 8th Biotech Showcase conference

BIBA Publishing- 15th January 2016

Latest News

Insertable cardiac monitors may help decide safe discontinuation of oral anticoagulation in AF patients at high risk of bleeding

BIBA Publishing- 4th December 2015

Features

ENSURE-AF: Largest trial ever to explore novel oral anticoagulation in AF patients undergoing cardioversion

BIBA Publishing- 10th February 2015

Latest News

Novel oral anticoagulants an option for patients with atrial fibrillation

BIBA Publishing- 26th June 2014

Features

Clinical strategies for selecting oral anticoagulants in atrial fibrillation patients

BIBA Publishing- 17th October 2013

Latest News

Indirect comparison of new anticoagulants provides insight into how the drugs compare

BIBA Publishing- 14th August 2012

Latest News

Watchman device shows 75% reduction in stroke risk in patients with atrial fibrillation not eligible for oral anticoagulation therapy

BIBA Publishing- 14th May 2012

Latest News

Edoxaban: Next generation oral anticoagulant under investigation

BIBA Publishing- 7th September 2009

Latest News

LAAC-related ischaemic stroke “less severe and less fatal” than with DOACs in AF patients

willdate- 27th November 2023

Latest News

Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”

jamiebell- 30th May 2023

Latest News

Experts update consensus on left atrial appendage closure

willdate- 31st March 2023

Latest News

HRS 2021: DOACs reduce risk of stroke in patients undergoing left ventricular RFA

willdate- 30th July 2021

Latest News

DOACs show better safety and effectiveness versus warfarin in patients with valvular AF

willdate- 1st April 2021

Latest News

AHA 2020: Rivaroxaban may be comparable to warfarin for bioprosthetic mitral valves, AF

willdate- 16th November 2020

Videos

President of Venice Arrhythmias discusses current challenges in atrial fibrillation management

Jocelyn Hudson- 9th October 2019

Latest News

Analysis of the BRUISE CONTROL 1 and 2 trials shows no difference in clinically significant haematoma between DOACs and warfarin

hannahwoolley- 27th June 2018

Latest News

New guidelines promote safety for patients on antithrombotic drugs undergoing anaesthesia or pain intervention

hannahwoolley- 10th April 2018

Latest News

Less bleeding in ablation with interrupted dabigatran compared to uninterrupted warfarin

hannahwoolley- 24th January 2018

Features

Antithrombotic therapy after left atrial appendage closure

BIBA Publishing- 10th September 2014

Latest News

AZALEA-TIMI 71 Phase 2 study ends early after “overwhelming” endpoint reduction

willdate- 19th September 2023

Latest News

Early rhythm control aids recurrent stroke prevention in patients with AF

Éva Malpass- 2nd March 2023

Latest News

ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI

Anthony Strzalek- 6th September 2021

Latest News

ACC.21: Registry data show low rate of stroke at one year following LAAO with Watchman

willdate- 16th May 2021

Latest News

Boston Scientific initiates CHAMPION-AF trial of Watchman FLX

willdate- 29th October 2020

Latest News

ESC Congress 2020: Guidelines push individualised approach to AF

willdate- 29th August 2020

Latest News

First procedures performed in the USA using Watchman FLX LAAC device

willdate- 10th August 2020

Features

Prompt diagnosis “vital” in effective AF management

willdate- 30th July 2020

Latest News

AF Symposium 2020: Use-as-needed NOAC strategy is safe and effective for selected AF patients

dawnpowell- 24th January 2020

Latest News

Pooled analysis shows LAAC is cheaper than drug therapy for AF

Angela O'Neill- 5th July 2019

Latest News

White paper from Heart Rhythm Society suggests Afib treatment has reached a “turning point”

Angela O'Neill- 6th June 2019

Latest News

CE mark for Watchman FLX left atrial appendage closure device

Jocelyn Hudson- 13th March 2019

Latest News

Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and may have a positive effect on cognitive function

hannahwoolley- 1st June 2018

Latest News

Point-of-care testing of coagulation in patients treated with edoxaban

hannahwoolley- 31st May 2018

Latest News

Octreotide enables left atrial appendage closure in AF patients with GI bleeding

hannahwoolley- 31st May 2018

Profiles

Nassir Marrouche

hannahwoolley- 4th May 2018

Latest News

Dabigatran consistently shown to decrease risk of brain bleeds compared to warfarin

zohman- 15th November 2017

Latest News

Vivek Reddy on the final outcomes of PREVAIL and PROTECT-AF

zohman- 3rd November 2017

Latest News

Significant differences among atrial fibrillation patients across Asia

dawnpowell- 18th September 2017

Profiles

Carlos Morillo

Angela O'Neill- 15th June 2017

Latest News

Four out of 10 AF patients may not receive necessary stroke-prevention medication

amanda- 15th May 2017

Latest News

Surgical left atrial appendage occlusion reduces thromboembolic stroke and mortality in older AF patients

Angela O'Neill- 4th May 2017

Latest News

ACC 2017: Uninterrupted dabigatran performs better than warfarin in atrial fibrillation ablation

Angela O'Neill- 21st March 2017

Latest News

Case strengthens for opportunistic atrial fibrillation screening

Angela O'Neill- 5th January 2017

Latest News

Health Canada approves edoxaban for two indications

amanda- 10th November 2016

Latest News

Portola license Japanese commercial rights for andexanet alfa to Bristol-Myers Squibb and Pfizer

BIBA Publishing- 2nd February 2016

Latest News

NICE recommends once-daily Lixiana (edoxaban) for preventing stroke and systemic embolism in non-valvular atrial fibrillation patients

BIBA Publishing- 23rd September 2015

Latest News

First patient enrolled in study of Eliquis (apixaban) in NVAF patients with recent acute coronary syndrome or undergoing PCI

BIBA Publishing- 10th September 2015

Latest News

Global registry presents two-year outcomes data in more than 17,000 newly-diagnosed AF patients

BIBA Publishing- 2nd September 2015

Features

Highlights EHRA EUROPACE-CARDIOSTIM 2015: Interview with Michael Glikson

BIBA Publishing- 16th July 2015

Latest News

Benefit of anticoagulation in AF patients with a low risk of stroke questioned

BIBA Publishing- 18th June 2015

Latest News

First patient enrolled in dabigatran study comparing anticoagulation strategies during atrial fibrillation ablation

BIBA Publishing- 26th May 2015

Latest News

Phase 3 ANNEXA-R study of andexanet alfa and factor Xa inhibitor Xarelto meets primary endpoint

BIBA Publishing- 5th February 2015

Features

Get With The Guidelines-AFIB: A US quality improvement programme for atrial fibrillation patients

BIBA Publishing- 27th January 2015

Profiles

Massimo Santini

BIBA Publishing- 10th October 2014

Latest News

Joint consensus on antithrombotic use in AF patients with acute coronary syndrome published

BIBA Publishing- 27th August 2014

Latest News

Bristol-Myers Squibb and Pfizer to present new Eliquis (apixaban) data at ESC

BIBA Publishing- 22nd August 2014

Latest News

New study of Pradaxa to explore anticoagulation in ablation of AF patients

BIBA Publishing- 20th June 2014

Latest News

Daiichi Sankyo initiates phase 3 ENSURE-AF study

BIBA Publishing- 1st April 2014

Latest News

Detection of atrial fibrillation with insertable cardiac monitors is superior to standard monitoring in cryptogenic stroke patients

BIBA Publishing- 20th February 2014

Features

Rivaroxaban prevents prothrombogenic remodelling of human atrial myocardium

BIBA Publishing- 18th December 2013

Latest News

UK’s NICE supports improved commissioning for anticoagulation therapy for adults

BIBA Publishing- 15th May 2013

Latest News

Rivaroxaban to be studied with Factor Xa inhibitor antidote

BIBA Publishing- 6th February 2013

Features

The use of dabigatran in clinical practice

BIBA Publishing- 28th January 2013

Profiles

Gregory YH Lip

BIBA Publishing- 23rd January 2013

Latest News

European Commission approves apixaban for prevention of stroke and systemic embolism in non-valvular atrial fibrillation patients

BIBA Publishing- 21st November 2012

Latest News

Dabigatran etexilate recommended for approval for stroke prevention in AF patients in Europe

BIBA Publishing- 27th April 2011

Features

Worldwide survey shows ablation works without drugs in most cases

BIBA Publishing- 7th July 2010

Profiles

Riccardo Cappato

BIBA Publishing- 16th July 2009

Latest News

Voice response system useful for monitoring anticoagulant patients

BIBA Publishing- 28th April 2009

Latest News

Final patient completes treatment in the RE-LY study

BIBA Publishing- 23rd March 2009